Atomic Invest’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Atomic Invest's BMY Position: Q3 2026 in Review
Atomic Invest increased its Bristol-Myers Squibb (BMY) stake by 9.1% in Q3 2026, buying an estimated $2.15K and bringing the position to 409 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #214.
Atomic Invest first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. The position peaked at $26.5K in Q1 2026. 2,533 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Atomic Invest held 409 shares of Bristol-Myers Squibb worth $25.5K as of Q3 2026.
- Atomic Invest bought 34 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.15K.
- Bristol-Myers Squibb made up ﹤0.01% of Atomic Invest's portfolio in Q3 2026, its #214 holding.
- Atomic Invest first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
- Atomic Invest's Bristol-Myers Squibb position peaked at $26.5K in Q1 2026.
- 2,533 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Atomic Invest's 13F filing for Q3 2026, filed 13 Nov 2026.